Thalidomide-4,5-F
Thalidomide-4,5-F is a fluorinated Thalidomide analogue. Thalidomide promotes the ubiquitinylation of proteins. The structure may be further derivatized via substitution at its fluorines.
Product Specifications
CAS Number
[2222115-19-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Ligands for E3 Ligase
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.0
Smiles
O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC(F)=C3F)=O
Molecular Formula
C13H8F2N2O4
Molecular Weight
294.21
Precautions
H302, H315, H319
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
043664-PE 200 µL
USP20, ID (USP20, KIAA1003, LSFR3A, VDU2, Ubiquitin carboxyl-terminal hydrolase 20, Deubiquitinating enzyme 20, Ubiquitin thioesterase 20, Ubiquitin-specific-processing protease 20, VHL-interacting deubiquitinating enzyme 2) (PE) discontinued
Ask
View Details 
MBS2073084-01 0.1 mL
PE-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073084-02 0.2 mL
PE-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073084-03 0.5 mL
PE-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details MBS2073084-04 1 mL
PE-Linked Polyclonal Antibody to Phospholipase A2, Group IIA (PLA2G2A)
Ask
View Details